Statin and outcomes of coronavirus disease 2019 (COVID-19): A systematic review, meta-analysis, and meta-regression

AIMS: One of the comorbidities associated with severe outcome and mortality of COVID-19 is dyslipidemia. Statin is one of the drugs which is most commonly used for the treatment of dyslipidemic patients. This study aims to analyze the association between statin use and composite poor outcomes of COV...

Descripción completa

Detalles Bibliográficos
Autores principales: Hariyanto, Timotius I., Kurniawan, Andree
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. 2021
Materias:
Systematic Reviews and Meta-analyses
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910652/
https://www.ncbi.nlm.nih.gov/pubmed/33838992
http://dx.doi.org/10.1016/j.numecd.2021.02.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910652/
https://www.ncbi.nlm.nih.gov/pubmed/33838992
http://dx.doi.org/10.1016/j.numecd.2021.02.020

Ejemplares similares